This system employs a self-sustaining enzymatic cascade: CAT alleviates hypoxia by converting tumor-derived H2O2 into oxygen, while LOX depletes lactate and generates additional H2O2 to fuel CAT activity, synergistically amplifying ROS production. This evidence concerns the gene LOX and neoplasm.